News
Masters Pharmaceuticals Limited announces partnership with Santhera Pharmaceuticals (Switzerland) to enable patients in the United States access to Catena (INN: idebenone)
Masters Pharmaceuticals Limited is pleased to announce its partnership with Santhera Pharmaceuticals of Switzerland to enable patients in the United States of America access to Catena® (INN: idebenone) starting March 15th 2012.
- Tue 14th Dec 2010

National Ataxia Foundation 55th Annual Membership Meeting March 15 - 18, 2012
This year’s National Ataxia Foundation Annual Membership Meeting, "Roundin' Up a Cure to Give Ataxia the Boot", takes place in San Antonio, Texas. Please follow the link for further information.
- Tue 14th Dec 2010

Rare Disease Day 29th February, 2012, Patients and Researchers, Partners for Life!
On 29th February, 2012 the National Institute of Health (NIH) will celebrate the 5th annual Rare Disease Day with a day-long celebration and recognition of the various rare diseases and research activities supported by the NIH Office of Rare Diseases Research, the NIH Clinical Centre, other NIH Institutes and Centres; the Food and Drug Administration's Office of Orphan Product Development; the National Organisation for Rare Disorders; and the Genetic Alliance. Rare Disease Day at NIH (RDD@NIH) will be held in the Clinical Centre's Masur Auditorium (Building 10) from 8:30 am to 5:00 pm. Attendance is free and it is open to the public.
Please follow the link below to find out more about Rare Disease Day:
- Tue 14th Dec 2010

Information on Unlicensed Products: Mastocytosis
Mastocytosis is a rare disease that occurs in both children and adults. It is characterized by the presence of too many mast cells in connective tissues such as the skin, the lining of the stomach, intestine and other sites. Mast cells play a critical role in the immune system’s response to defend the body against infection and disease.
- Tue 14th Dec 2010






